News Website

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Published: April 11, 2026, 11:01 a.m.

Read Full Article

In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan

In recurrent endometrial cancer, BioNTech drug held off progression 8 months Stock Titan

Published: April 11, 2026, 11 a.m.

Read Full Article

Progesterone in MHT for Protection Against Endometrial Cancer - The Vajenda

Progesterone in MHT for Protection Against Endometrial Cancer The Vajenda

Published: April 11, 2026, 9:17 a.m.

Read Full Article

THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE - PressReader

THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE PressReader

Published: April 11, 2026, 12:01 a.m.

Read Full Article

USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis - MSN

USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis MSN

Published: April 10, 2026, 7:29 p.m.

Read Full Article

Menstrual Disorders Reducing Women’s Productivity, Experts Raise Alarm - freedomonline.com.ng

Menstrual Disorders Reducing Women’s Productivity, Experts Raise Alarm freedomonline.com.ng

Published: April 10, 2026, 7:02 p.m.

Read Full Article

Prince Harry sued by charity he set up in Africa to honor late mother Princess Diana - 13newsnow.com

Prince Harry sued by charity he set up in Africa to honor late mother Princess Diana 13newsnow.com

Published: April 10, 2026, 6:14 p.m.

Read Full Article

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today

Published: April 10, 2026, 4:35 p.m.

Read Full Article

Janel Parrish splits from husband amid speculation she’s seeing ‘DWTS’ pro - New York Daily News

Janel Parrish splits from husband amid speculation she’s seeing ‘DWTS’ pro New York Daily News

Published: April 10, 2026, 3:14 p.m.

Read Full Article

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - StreetInsider

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer StreetInsider

Published: April 10, 2026, 11:01 a.m.

Read Full Article

Latest Articles

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan

Progesterone in MHT for Protection Against Endometrial Cancer - The Vajenda

THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE - PressReader

USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis - MSN

Menstrual Disorders Reducing Women’s Productivity, Experts Raise Alarm - freedomonline.com.ng

Prince Harry sued by charity he set up in Africa to honor late mother Princess Diana - 13newsnow.com

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today

Janel Parrish splits from husband amid speculation she’s seeing ‘DWTS’ pro - New York Daily News

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - StreetInsider

Subscribe to Our Newsletter